businessJan 29, 20269:22pending
2299: Poolbeg Pharma: POLB 001 Clinical Data Published — What’s Next for This Immunomodulatory Asset?
About this episode
Following the publication of a peer-reviewed paper in Frontiers in Immunology detailing results from the POLB 001 LPS challenge trial, we catch up with Poolbeg Pharma’s CEO Jeremy Skillington and COO Liam Tremble.
Get every episode summarized
Each time The Vox Markets Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Vox Markets Podcast
2369: Poolbeg hits significant milestone with POLB 001
The Vox Markets Podcast
Apr 15, 20266:18failed
2368: hVIVO FY25 Results: Growth, Acquisitions and What Comes Next in 2026
The Vox Markets Podcast
Apr 15, 20268:41failed
2367: Quantum Data Energy CEO on Q1 Progress
The Vox Markets Podcast
Apr 15, 202611:52failed
2366: Chancery Royalty gets set for US$7,000 gold
The Vox Markets Podcast
Apr 14, 202613:58failed